Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights
Category: Business
Share
Archive
Like
NEW YORK--(BUSINESS WIRE)--Sep 8, 2026--
Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29, 2025 and June 29, 2026. Unicycive describes itself as a 'a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases.'
A note on cookies
Newshunt uses essential cookies to keep you signed in and to remember your language and country, so the site works the way you expect. With your permission, we'd also like to use analytics cookies to understand how people use Newshunt and improve it over time.
Accepting only affects analytics. To learn more, view our Privacy Policy or Terms & Conditions.
(0)Comments